Electronic records, electronic signatures and Good Practice (GxP) compliance for clinical research and regulated systems
| System Name | System Type | Validation Status | Last Validation | Audit Trail | E-Sig Compliant | Risk Level | Actions |
|---|
| System | Phase | IQ | OQ | PQ | Validation Report | Status | Due Date |
|---|
FDA guidance requires periodic review of audit trails for GxP systems. Critical systems: monthly. Others: quarterly.
| System | Review Frequency | Last Review | Next Due | Reviewer | Status |
|---|